Manipulation of adult body composition by treatment of the neonatal rat with growth hormone and prolactin

I. T. Kadim, S. N. McCutcheon, R. W. Purchas, G. A. Wickham

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Previous studies involving fetal decapitation or hypophysectomy, and the treatment of neonates with hormones or antibodies, have suggested that changes in pituitary hormone status during the perinatal period may influence later body composition. In the present study, rats were treated for the first 21 days of life with twice daily subcutaneous injections of saline, recombinant bovine growth hormone (bGH) or pituitary ovine prolactin (oPRL). The bGH and oPRL were administered at doses of 0.2 or 0.4 μg/g bodyweight/day. One-third of the rats in each treatment group were slaughtered at each of days 21, 60 and 120 of life and measurements made of: length and weight of the body; weights of bones and muscle groups in the hindlimb; weights of four fat depots (120-day group only); and the content of nitrogen (N) and fat in the carcass. bGH, but not oPRL, treatment increased weight of the femur and humerus (across ages) but neither treatment had marked effects on weights of muscle groups, carcass weight or carcass N content at any age. Both bGH and oPRL treatment significantly reduced weight of the subcutaneous scapular fat depot and reduced carcass fat content, but only in animals aged 120 days (i.e. 99 days after the cessation of treatment). It is concluded that treatment of rats with bGH and oPRL during the immediate postnatal period specifically retards the ability of animals to deposit body fat in later Life by mechanisms which differ from those involved in the classical lipolytic/antilipogenic effects of bGH.

Original languageEnglish
Pages (from-to)201-205
Number of pages5
JournalGrowth Regulation
Volume6
Issue number4
Publication statusPublished - 1996

Fingerprint

Body Composition
Prolactin
Growth Hormone
Sheep
Weights and Measures
Fats
Therapeutics
Decapitation
Muscles
Hypophysectomy
Withholding Treatment
Pituitary Hormones
Subcutaneous Fat
Humerus
Subcutaneous Injections
Hindlimb
Femur
bovine growth hormone
Adipose Tissue
Nitrogen

Keywords

  • bGH
  • Body composition
  • Neonate
  • oPRL

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Manipulation of adult body composition by treatment of the neonatal rat with growth hormone and prolactin. / Kadim, I. T.; McCutcheon, S. N.; Purchas, R. W.; Wickham, G. A.

In: Growth Regulation, Vol. 6, No. 4, 1996, p. 201-205.

Research output: Contribution to journalArticle

Kadim, I. T. ; McCutcheon, S. N. ; Purchas, R. W. ; Wickham, G. A. / Manipulation of adult body composition by treatment of the neonatal rat with growth hormone and prolactin. In: Growth Regulation. 1996 ; Vol. 6, No. 4. pp. 201-205.
@article{c32bf2e58ddd467bbf8aef9cdf4a8405,
title = "Manipulation of adult body composition by treatment of the neonatal rat with growth hormone and prolactin",
abstract = "Previous studies involving fetal decapitation or hypophysectomy, and the treatment of neonates with hormones or antibodies, have suggested that changes in pituitary hormone status during the perinatal period may influence later body composition. In the present study, rats were treated for the first 21 days of life with twice daily subcutaneous injections of saline, recombinant bovine growth hormone (bGH) or pituitary ovine prolactin (oPRL). The bGH and oPRL were administered at doses of 0.2 or 0.4 μg/g bodyweight/day. One-third of the rats in each treatment group were slaughtered at each of days 21, 60 and 120 of life and measurements made of: length and weight of the body; weights of bones and muscle groups in the hindlimb; weights of four fat depots (120-day group only); and the content of nitrogen (N) and fat in the carcass. bGH, but not oPRL, treatment increased weight of the femur and humerus (across ages) but neither treatment had marked effects on weights of muscle groups, carcass weight or carcass N content at any age. Both bGH and oPRL treatment significantly reduced weight of the subcutaneous scapular fat depot and reduced carcass fat content, but only in animals aged 120 days (i.e. 99 days after the cessation of treatment). It is concluded that treatment of rats with bGH and oPRL during the immediate postnatal period specifically retards the ability of animals to deposit body fat in later Life by mechanisms which differ from those involved in the classical lipolytic/antilipogenic effects of bGH.",
keywords = "bGH, Body composition, Neonate, oPRL",
author = "Kadim, {I. T.} and McCutcheon, {S. N.} and Purchas, {R. W.} and Wickham, {G. A.}",
year = "1996",
language = "English",
volume = "6",
pages = "201--205",
journal = "Growth Regulation",
issn = "0956-523X",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Manipulation of adult body composition by treatment of the neonatal rat with growth hormone and prolactin

AU - Kadim, I. T.

AU - McCutcheon, S. N.

AU - Purchas, R. W.

AU - Wickham, G. A.

PY - 1996

Y1 - 1996

N2 - Previous studies involving fetal decapitation or hypophysectomy, and the treatment of neonates with hormones or antibodies, have suggested that changes in pituitary hormone status during the perinatal period may influence later body composition. In the present study, rats were treated for the first 21 days of life with twice daily subcutaneous injections of saline, recombinant bovine growth hormone (bGH) or pituitary ovine prolactin (oPRL). The bGH and oPRL were administered at doses of 0.2 or 0.4 μg/g bodyweight/day. One-third of the rats in each treatment group were slaughtered at each of days 21, 60 and 120 of life and measurements made of: length and weight of the body; weights of bones and muscle groups in the hindlimb; weights of four fat depots (120-day group only); and the content of nitrogen (N) and fat in the carcass. bGH, but not oPRL, treatment increased weight of the femur and humerus (across ages) but neither treatment had marked effects on weights of muscle groups, carcass weight or carcass N content at any age. Both bGH and oPRL treatment significantly reduced weight of the subcutaneous scapular fat depot and reduced carcass fat content, but only in animals aged 120 days (i.e. 99 days after the cessation of treatment). It is concluded that treatment of rats with bGH and oPRL during the immediate postnatal period specifically retards the ability of animals to deposit body fat in later Life by mechanisms which differ from those involved in the classical lipolytic/antilipogenic effects of bGH.

AB - Previous studies involving fetal decapitation or hypophysectomy, and the treatment of neonates with hormones or antibodies, have suggested that changes in pituitary hormone status during the perinatal period may influence later body composition. In the present study, rats were treated for the first 21 days of life with twice daily subcutaneous injections of saline, recombinant bovine growth hormone (bGH) or pituitary ovine prolactin (oPRL). The bGH and oPRL were administered at doses of 0.2 or 0.4 μg/g bodyweight/day. One-third of the rats in each treatment group were slaughtered at each of days 21, 60 and 120 of life and measurements made of: length and weight of the body; weights of bones and muscle groups in the hindlimb; weights of four fat depots (120-day group only); and the content of nitrogen (N) and fat in the carcass. bGH, but not oPRL, treatment increased weight of the femur and humerus (across ages) but neither treatment had marked effects on weights of muscle groups, carcass weight or carcass N content at any age. Both bGH and oPRL treatment significantly reduced weight of the subcutaneous scapular fat depot and reduced carcass fat content, but only in animals aged 120 days (i.e. 99 days after the cessation of treatment). It is concluded that treatment of rats with bGH and oPRL during the immediate postnatal period specifically retards the ability of animals to deposit body fat in later Life by mechanisms which differ from those involved in the classical lipolytic/antilipogenic effects of bGH.

KW - bGH

KW - Body composition

KW - Neonate

KW - oPRL

UR - http://www.scopus.com/inward/record.url?scp=0029751261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029751261&partnerID=8YFLogxK

M3 - Article

C2 - 8971548

AN - SCOPUS:0029751261

VL - 6

SP - 201

EP - 205

JO - Growth Regulation

JF - Growth Regulation

SN - 0956-523X

IS - 4

ER -